Physician profile
Michael W Laker
NPI 1043353444
$10,049.66
in general payments reported to CMS, 2019-2025
10 companies · $7,804 in 2025
The $7,804 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $134 · 2021: $975 · 2022: $180 · 2023: $417 · 2024: $364 · 2025: $7,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,363 · Food and Beverage: $1,195 · Travel and Lodging: $27.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,363.14 |
| Food and Beverage | $1,194.58 |
| Travel and Lodging | $27.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,559.09 | 2021-2025 | |
| Depuy Synthes Sales INC. | $1,578.66 | 2019-2025 | Velys, Inhance, Na |
| Stryker Corporation | $584.12 | 2020-2023 | Gamma, Accolade, Exeter |
| Aroa Biosurgery Incorporated | $155.07 | 2024 | |
| Bioventus LLC | $74.67 | 2021-2022 | |
| Pacira Therapeutics, INC. | $29.11 | 2019 | |
| Acera Surgical, INC. | $20.93 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $16.22 | 2025 | Inceptiv |
| Zimmer Biomet Holdings, INC. | $16.18 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.61 | 2023 | Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Laker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.